Merck loses latest fight over parallel imports
Another detail of the law regarding repackaging pharmaceutical products in the EU has been clarified: it doesn’t matter if the importer doesn’t name the company that actually did the repackaging
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: